EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 92 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $38,836 | -24.0% | 43,300 | 0.0% | 0.00% | – |
| Q4 2022 | $51,094 | -81.1% | 43,300 | +20.3% | 0.00% | – |
| Q3 2022 | $271,000 | +29.7% | 36,000 | +8.4% | 0.00% | – |
| Q2 2022 | $209,000 | -14.3% | 33,200 | +12.9% | 0.00% | – |
| Q1 2022 | $244,000 | +59.5% | 29,400 | 0.0% | 0.00% | – |
| Q4 2021 | $153,000 | -26.8% | 29,400 | -6.1% | 0.00% | – |
| Q3 2021 | $209,000 | -21.7% | 31,300 | 0.0% | 0.00% | – |
| Q2 2021 | $267,000 | +0.4% | 31,300 | +4.3% | 0.00% | – |
| Q1 2021 | $266,000 | -27.9% | 30,000 | 0.0% | 0.00% | – |
| Q4 2020 | $369,000 | +51.2% | 30,000 | 0.0% | 0.00% | – |
| Q3 2020 | $244,000 | -15.3% | 30,000 | 0.0% | 0.00% | – |
| Q2 2020 | $288,000 | +119.8% | 30,000 | +55.4% | 0.00% | – |
| Q1 2020 | $131,000 | -14.4% | 19,300 | +87.4% | 0.00% | – |
| Q4 2019 | $153,000 | +44.3% | 10,300 | 0.0% | 0.00% | – |
| Q3 2019 | $106,000 | – | 10,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 1,787,091 | $14,118,000 | 3.56% |
| INTERWEST VENTURE MANAGEMENT CO | 1,599,592 | $12,637,000 | 2.99% |
| SPHERA FUNDS MANAGEMENT LTD. | 385,301 | $3,044,000 | 0.52% |
| Boxer Capital, LLC | 138,331 | $1,093,000 | 0.26% |
| DAFNA Capital Management LLC | 35,977 | $284,000 | 0.20% |
| SABBY MANAGEMENT, LLC | 223,100 | $1,762,000 | 0.12% |
| Hikari Power Ltd | 60,992 | $482,000 | 0.06% |
| Perceptive Advisors | 157,679 | $1,245,000 | 0.06% |
| Lombard Odier Asset Management (USA) Corp | 90,000 | $711,000 | 0.06% |
| TFS CAPITAL LLC | 12,128 | $96,000 | 0.04% |